当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析 - 现金流量表

东方生物

(688298)

  

流通市值:44.15亿  总市值:44.15亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金277,921,807.02987,470,919.91686,034,931.2459,201,097.93
  收到的税费返还15,216,296.1241,852,899.0433,046,574.5222,165,227.65
  收到其他与经营活动有关的现金40,016,546.0248,969,681.1272,722,726.2539,005,893.97
  经营活动现金流入小计333,154,649.161,078,293,500.07791,804,231.97520,372,219.55
  购买商品、接受劳务支付的现金120,192,921.96389,575,168.46327,921,176.02219,447,428.8
  支付给职工以及为职工支付的现金136,828,467.85517,655,491.53356,587,056.88247,738,027.65
  支付的各项税费17,015,589.4336,374,980.8934,469,429.6426,030,220.65
  支付其他与经营活动有关的现金88,226,426.12328,586,907.75227,459,359.26150,427,133.43
  经营活动现金流出小计362,263,405.361,272,192,548.63946,437,021.8643,642,810.53
  经营活动产生的现金流量净额-29,108,756.2-193,899,048.56-154,632,789.83-123,270,590.98
二、投资活动产生的现金流量:
  收回投资收到的现金202,390,502.41466,088,560.25500,694,127.14263,200,517.99
  取得投资收益收到的现金443,327.749,285,727.171,665,124.38818,920.01
  处置固定资产、无形资产和其他长期资产收回的现金净额4,1052,615,756.22313,562.45300,142.45
  收到的其他与投资活动有关的现金79,989,111.181,625,094,230.213,778,942,720.642,686,177,147.78
  投资活动现金流入小计282,827,046.332,103,084,273.854,281,615,534.612,950,496,728.23
  购建固定资产、无形资产和其他长期资产支付的现金132,827,020.28307,667,970.63269,792,868.01207,589,449.21
  投资支付的现金245,826,933.25416,553,139.64334,307,881.48380,366,804.87
  取得子公司及其他营业单位支付的现金0--0
  支付其他与投资活动有关的现金622,547,038.52801,262,146.683,991,221,500.922,159,142,202.61
  投资活动现金流出小计1,001,200,992.051,525,483,256.954,595,322,250.412,747,098,456.69
  投资活动产生的现金流量净额-718,373,945.72577,601,016.9-313,706,715.8203,398,271.54
三、筹资活动产生的现金流量:
  吸收投资收到的现金186,0000-0
  其中:子公司吸收少数股东投资收到的现金186,000---
  取得借款收到的现金64,117,005.3384,000,000346,000,000271,000,000
  收到其他与筹资活动有关的现金28,492,298.6902,281,234.10
  筹资活动现金流入小计92,795,303.99384,000,000348,281,234.1271,000,000
  偿还债务支付的现金61,000,000510,060,000500,000,000406,000,000
  分配股利、利润或偿付利息支付的现金1,272,700.8341,117,451.25,600,403.213,593,697.65
  其中:子公司支付给少数股东的股利、利润-34,405,757.37-0
  支付其他与筹资活动有关的现金2,585,593.3466,704,007.4963,394,252.799,773,839.09
  筹资活动现金流出小计64,858,294.17617,881,458.69568,994,656419,367,536.74
  筹资活动产生的现金流量净额27,937,009.82-233,881,458.69-220,713,421.9-148,367,536.74
四、汇率变动对现金及现金等价物的影响-24,957,288.44-24,409,916.74-2,910,406.581,645,378.84
五、现金及现金等价物净增加额-744,502,980.54125,410,592.91-691,963,334.11-66,594,477.34
  加:期初现金及现金等价物余额1,635,685,891.791,510,275,298.881,510,275,298.881,510,275,298.88
  期末现金及现金等价物余额891,182,911.251,635,685,891.79818,311,964.771,443,680,821.54
补充资料:
  净利润--597,405,207.55--174,059,798.07
  资产减值准备-199,366,343.14-13,924,362.69
  固定资产和投资性房地产折旧-99,727,986.03-46,512,213.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-99,727,986.03-46,512,213.64
  无形资产摊销-79,416,852.51-39,389,221.51
  长期待摊费用摊销-23,611,801.12-10,992,251.1
  处置固定资产、无形资产和其他长期资产的损失--1,748,605.93--1,741,743.14
  固定资产报废损失-80,190.48-80,221.82
  公允价值变动损失-1,596,613.77--4,992,565.99
  财务费用-14,961,338.09--13,603,947.38
  投资损失--8,681,541.5--3,484,332.15
  递延所得税-12,161,015.42--252,839.01
  其中:递延所得税资产减少-12,350,615.94--129,707.65
    递延所得税负债增加--189,600.52--123,131.36
  存货的减少--26,628,553.52--18,012,620.13
  经营性应收项目的减少--71,207,168.47--42,631.99
  经营性应付项目的增加-56,400,578--26,938,579.16
  现金的期末余额-1,635,685,891.79-1,443,680,821.54
  减:现金的期初余额-1,510,275,298.88-1,510,275,298.88
  现金及现金等价物的净增加额-125,410,592.91--66,594,477.34
公告日期2026-04-292026-04-292025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑